Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Zhenyuan Pharmaceutical has a long-standing history as a major Chinese manufacturer of bulk antibiotics and finished dosage forms. The company’s portfolio includes macrolides (azithromycin and derivatives), aminoglycosides, cephalosporins, and related anti-infectives. Its products are widely used for the treatment of various bacterial infections and are available in both domestic and international markets. No recent clinical trial data or novel drug development results have been disclosed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Zhenyuan Pharmaceutical.